UBS analyst Matthew Weston upgraded Roche Holding (OTC:RHHBY) stock from Neutral to Buy, adjusting the price target to CHF 338.00, up from the previous CHF 300.00. The upgrade comes as the stock ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study <li /> Independent interim analysis of the E.mbrace phase 3 s ...